Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Londo who wrote (6036)	6/18/2002 9:20:22 AM
From: Biomaven	Read Replies (3) \| Respond to of 10280

<OT> once they implement proper expense accounting of options As it happens, I think I have more practical experience with expense accounting of options under FAS 123 than anyone else in the US. Based on that experience, I'd say it's generally about as realistic as Enron accounting. You have to estimate factors like future volatility and option life that there is no sensible way to estimate. For some imploding telecom companies in 2002, there was actually a net credit from option expenses because of the impact of all their employee terminations and consequent option forfeitures causing a reversal of prior-year expenses. Is that really a number you want folded into reported earnings? Peter